Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-29 @ 9:14 AM
Study NCT ID:
NCT00370292
Status:
COMPLETED
Last Update Posted:
2009-10-20
First Post:
2006-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-29
First Submit QC Date:
None
Study First Post Date:
2006-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-09-09
Results First Submit QC Date:
None
Results First Post Date:
2009-10-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-10-15
Last Update Post Date:
2009-10-20
Last Update Post Date Type:
ESTIMATED